Braskem (NYSE:BAK) Downgraded by Wall Street Zen to Sell

Braskem logo with Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Wall Street Zen downgraded Braskem from “hold” to “sell.” Analysts’ overall view is strongly negative: five rate the stock Sell and three Hold, with a consensus price target of $2.41.
  • Braskem reported a quarterly loss of $0.52 per share, missing the $0.02-per-share consensus estimate, although revenue of $3.78 billion topped expectations.
  • Shares opened at $0.74, near the company’s one-year low of $0.73; UBS also cut its price target from $1.50 to $0.75 and maintained a Sell rating.
  • MarketBeat previews top five stocks to own in December.

Braskem (NYSE:BAK - Get Free Report) was downgraded by research analysts at Wall Street Zen from a "hold" rating to a "sell" rating in a report issued on Saturday, Wall Street Zen reports.

Several other equities analysts also recently issued reports on BAK. UBS Group cut their price target on shares of Braskem from $1.50 to $0.75 and set a "sell" rating for the company in a report on Thursday. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Braskem in a research note on Thursday, October 15th. Finally, HSBC lowered shares of Braskem from a "buy" rating to a "hold" rating and dropped their price objective for the stock from $6.50 to $1.50 in a report on Monday, September 28th. Three investment analysts have rated the stock with a Hold rating and five have given a Sell rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Strong Sell" and a consensus target price of $2.41.

Read Our Latest Report on BAK

Braskem Price Performance

Shares of BAK stock opened at $0.74 on Friday. The stock's fifty day simple moving average is $1.45 and its 200 day simple moving average is $2.84. The firm has a market cap of $296.32 million, a price-to-earnings ratio of 0.42 and a beta of 1.68. Braskem has a one year low of $0.73 and a one year high of $5.39.

Braskem (NYSE:BAK - Get Free Report) last issued its quarterly earnings data on Friday, November 13th. The company reported ($0.52) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.02 by ($0.54). Braskem had a negative net margin of 8.40% and a negative return on equity of 45.63%. The company had revenue of $3.78 billion for the quarter, compared to the consensus estimate of $3.64 billion. On average, research analysts anticipate that Braskem will post -0.33 earnings per share for the current year.

Hedge Funds Weigh In On Braskem

Several institutional investors have recently modified their holdings of the business. Cetera Investment Advisers acquired a new position in Braskem in the 1st quarter worth $51,000. SBI Securities Co. Ltd. raised its holdings in Braskem by 393.2% during the third quarter. SBI Securities Co. Ltd. now owns 25,105 shares of the company's stock worth $36,000 after acquiring an additional 20,015 shares in the last quarter. Citadel Advisors LLC acquired a new position in Braskem during the second quarter valued at approximately $89,000. Bank of America Corp DE boosted its position in Braskem by 178,471.4% during the first quarter. Bank of America Corp DE now owns 50,000 shares of the company's stock valued at $183,000 after purchasing an additional 49,972 shares during the last quarter. Finally, Ramsey Quantitative Systems acquired a new position in Braskem during the second quarter valued at approximately $155,000.

About Braskem

(Get Free Report)

Braskem is a Brazilian petrochemical company that produces thermoplastic resins and basic petrochemicals used in packaging, construction, automotive manufacturing, consumer goods and other industries. Its products include polyethylene, polypropylene and polyvinyl chloride, as well as chemical building blocks such as ethylene and propylene. The company also makes bio-based plastics, including polyethylene produced from sugarcane-derived ethanol and marketed under its I'm green brand. These materials are designed to serve applications similar to those of conventional plastics.

Recommended Stories

Analyst Recommendations for Braskem (NYSE:BAK)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Braskem Right Now?

Before you consider Braskem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Braskem wasn't on the list.

While Braskem currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines